Health at a Glance 2015
Hide / Show Abstract

Health at a Glance 2015

OECD Indicators

This new edition of Health at a Glance presents the most recent comparable data on the performance of health systems in OECD countries. Where possible, it also reports data for partner countries (Brazil, China, Colombia, Costa Rica, India, Indonesia, Latvia, Lithuania, Russian Federation and South Africa). Compared with the previous edition, this new edition includes a new set of dashboards of health indicators to summarise in a clear and user-friendly way the relative strengths and weaknesses of OECD countries on different key indicators of health and health system performance, and also a special focus on the pharmaceutical sector. This edition also contains new indicators on health workforce migration and on the quality of health care.

Click to Access: 
    http://oecd.metastore.ingenta.com/content/health_glance-2015-en/00/01/index.html
  • WEB
  • http://oecd.metastore.ingenta.com/content/8115071e.pdf
  • PDF
  • http://oecd.metastore.ingenta.com/content/812015071f1.epub
  • ePUB
  • http://www.keepeek.com/Digital-Asset-Management/oecd/social-issues-migration-health/health-at-a-glance-2015_health_glance-2015-en
  • READ
 
Chapter
 

Research and development in the pharmaceutical sector You or your institution have access to this content

English
Click to Access: 
    http://oecd.metastore.ingenta.com/content/health_glance-2015-en/10/06/index.html
  • WEB
  • http://oecd.metastore.ingenta.com/content/8115071ec070.pdf
  • PDF
  • http://www.keepeek.com/Digital-Asset-Management/oecd/social-issues-migration-health/health-at-a-glance-2015/research-and-development-in-the-pharmaceutical-sector_health_glance-2015-70-en
  • READ
Author(s):
OECD

Hide / Show Abstract

The pharmaceutical industry devotes significant resources to research and development (R&D). In 2011, the industry spent USD 92 billion on R&D (OECD, 2015). This represents 10-15% of industry revenues.

Also available in French
 
Visit the OECD web site